Vitamins C, E do not cut heart attack, stroke risk: study

WASHINGTON (Reuters) - Neither vitamin C nor vitamin E supplements cuts the risk of cardiovascular disease including heart attack and stroke in a U.S. study published on Sunday.

And a second study failed to show that taking low-dose aspirin helped prevent heart and artery disease among Japanese people with diabetes.

Many people take vitamin supplements to try to ward off chronic disease. In a study aiming to establish whether they prevent heart disease, 14,641 doctors with an average age of 64 took either vitamin C, vitamin E or a placebo for an average of about eight years.

The men who took the vitamins ended up doing no better than those who took a placebo, researchers at Brigham and Women’s Hospital in Boston wrote in the Journal of the American Medical Association.

Vitamin E and vitamin C are antioxidants, thought to protect against damage caused by free radicals, substances that can harm cells, tissues and organs. Fruits and vegetables are rich in both, and it is well documented that people who eat plenty of plant foods have a lower risk of heart disease, cancer and other conditions.

“People should continue to focus on eating a healthy diet, exercising regularly and controlling known risk factors such as high cholesterol and high blood pressure to reduce the risk of cardiovascular disease,” Dr. Howard Sesso, one of the researchers, said in a statement.

“Unlike most previous studies in which vitamins E and C were given in combination with other antioxidants, this study investigated the two vitamins individually. Our findings add to the growing consensus about vitamin E and C’s lack of cardiovascular protection,” Dr. J. Michael Gaziano, one of the researchers, added in a statement.

Separately, a study involving 2,539 Japanese men and women with type 2 diabetes found that taking low doses of aspirin daily did not appear to reduce heart disease, stroke or peripheral arterial disease risk.

Heart attack and stroke are leading causes of death in people with type 2 diabetes, which is closely tied to obesity.

But a commentary by an Italian researcher accompanying the study in the Journal of the American Medical Association questioned whether findings involving a Japanese population with a comparatively low risk of cardiovascular disease can apply to people from other places where this disease risk is much higher.

“The use of aspirin for primary prevention of cardiovascular events in individuals with diabetes is widely recommended by existing guidelines, but the evidence supporting its efficacy is surprisingly scarce,” Dr. Antonio Nicolucci of Consorzio Mario Negri Sud in Italy wrote.

(Reporting by Will Dunham; Editing by Maggie Fox and Xavier Briand)


Related Posts:

LONDON (Reuters) - Doctors should not routinely give aspirin to people with diabetes to help guard against a heart attack or stroke, a British study found on Friday. While it was effective for those who had already developed heart disease or suffered a stroke, regular aspirin offered no benefit for patients with diabetes and a common

Full Post: Aspirin no heart protection for diabetics: study

By Will Dunham WASHINGTON (Reuters) - High doses of B vitamins failed to slow cognitive decline in people with Alzheimer’s disease, dashing the hopes for a new weapon against the fatal, mind-robbing ailment, U.S. researchers said on Tuesday. Experts had viewed B vitamins as a potential way to lower the risk of Alzheimer’s disease or slow its

Full Post: B vitamins fail in U.S. Alzheimer’s disease study

HONG KONG (Reuters) - A Japanese study conducted over 11 years has found that job stress can significantly increase the risk of stroke in men. The study, published in the Archives of Internal Medicine, involved 3,190 men and 3,363 women, aged 65 and younger. They were first interviewed between 1992 and 1995 and were then monitored

Full Post: Stressed men more likely to suffer stroke: study

NEW YORK (Reuters Health) - In the large Women’s Antioxidant Cardiovascular Study, participants who took beta carotene, vitamin C, vitamin E, or a combination of supplements had no significant reductions in their risk of cancer. The clinical trial, which involved 7,627 women who were followed for an average of 9.4 years, was conducted by Dr. Jennifer

Full Post: No cancer risk reductions seen with antioxidants

By Will Dunham WASHINGTON (Reuters) - Beta carotene, vitamin C and vitamin E supplements taken for years failed to lower overall cancer risk in the latest study to cast doubt on the possibility that such dietary supplements can prevent cancer. The findings, published on Tuesday in the Journal of the National Cancer Institute, followed two other important

Full Post: Antioxidants fail again in cancer prevention study

Site Navigation

Most Read